HAE III(81295-18-3)
- Name: HAE III
- Synonyms:BceQIRestriction endonuclease; BspRI; E.C. 3.1.23.17; Endodeoxyribonuclease BanAI;Endodeoxyribonuclease BluII; Endodeoxyribonuclease BspRI; EndodeoxyribonucleaseBsuI; Endodeoxyribonuclease HaeIII; Endodeoxyribonuclease HaeIIII;Endodeoxyribonuclease HhgI; Endodeoxyribonuclease PalI; EndodeoxyribonucleaseSfaI; Endodeoxyribonuclease SuaI; Endonuclease HaeIII; Endonuclease Z; HaeIII;Restiction endonuclease BshFI; Restriction endodeoxyribonuclease HaeIII;Restriction endodeoxyribonuclease HaeIII; Restriction endonuclase BsuR;Restriction endonuclease BanAI; Restriction endonuclease BecAII; Restrictionendonuclease Bim19II; Restriction endonuclease BliI; Restriction endonucleaseBme361I; Restriction endonuclease BsaRI; Restriction endonuclease BseI;Restriction endonuclease BseQI; Restriction endonuclease BshFI; Restrictionendonuclease BshI; Restriction endonuclease BspBR; Restriction endonucleaseBspRI; Restriction endonuclease BsuRI; Restriction endonuclease DsaII;Restriction endonuclease EsaBC4I; Restriction endonuclease HaeIII; Restrictionendonuclease MchAII; Restriction endonuclease MfoAI; Restriction endonucleaseMniI; Restriction endonuclease MthTI; Restriction endonuclease NgoPII;Restriction endonuclease NgoPIII; Restriction endonuclease NgoSII; Restrictionendonuclease NspLKI; Restriction endonuclease PalI; Restriction endonucleasePde133I; Restriction endonuclease PflKI; Restriction endonuclease PhoI;Restriction endonuclease PlaI; Restriction endonuclease Pru2I; Restrictionendonuclease SagI; Restriction endonuclease SbvI; Restriction endonucleaseSfaI; Restriction endonuclease SuaI; Restriction endonucleases Sp1III
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:81295-18-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 128718-50-3/11H-Benzofuro[2,3-b][1]benzopyran-11-one,1,3,8-trihydroxy-2-(2-hydroxy-3-methyl-3-butenyl)- (9CI)
- 80018-45-7/(6Z)-6-[(butylamino)(4-chlorophenyl)methylidene]-4-phenylcyclohexa-2,4-dien-1-one
- 139883-41-3/3-Nitro-2-pyridinesulfenyl dynorphin derivative
- 121306-82-9/5-phenyl-1-{[4-(trifluoromethyl)phenyl]carbonyl}-4,5-dihydro-1H-pyrazole
- 18437-79-1/Tris(4-fluorophenyl)phosphine
- 108664-44-4/1-[2-(thiophen-3-ylcarbonyl)prop-2-en-1-yl]pyridin-2(1H)-one
- 56524-75-5/1-[(4-chlorophenyl)sulfonyl]imidazolidin-2-one
- 58517-90-1/methyl 1-[1-[[[2-(hexadecyloxy)-5-[(methylamino)sulphonyl]phenyl]amino]carbonyl]-3,3-dimethyl-2-oxobutyl]-1H-imidazole-5-carboxylate
- 57595-88-7/7,8-dimethoxy-N-(prop-2-en-1-yl)-4,5-dihydronaphtho[1,2-d][1,3]thiazol-2-amine
- 71160-24-2/LEUKOTRIENE B4
- 83830-81-3/(3alpha,5beta)-3-hydroxy-12-oxocholan-24-oic acid
- 35464-74-5/formaldehyde, polymer with 3-methylphenol,4-methylphenol and phenol
- 2430-22-0/7-METHYL-1-OCTANOL
- 81295-18-3/HAE III
- 2425-51-6/sodium 9-octadecene-1-sulphonate
- 94442-04-3/disodium 4-[5-amino-4-[[2-methoxy-5-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-1H-pyrazol-1-yl]benzenesulphonate
- 4999-58-0/Dehydro-α-curcumene
- 5760-40-7/dimethyl 2,6-dimethyl-4-(4-methylphenyl)-1,4-dihydropyridine-3,5-dicarboxylate
- 64618-27-5/[1-(3,4-dichlorophenyl)-2,5-dimethyl-1H-pyrrole-3,4-diyl]dimethanediyl bis(methylcarbamate)
- 65995-51-9/2-methoxy-4-[(1E)-prop-1-en-1-yl]phenyl hexopyranoside
- 1852-43-3/ANDROSTERONE GLUCURONIDE CRYSTALLINE
- 19246-22-1/N-(2,6-Dioxo-3-piperidyl)-1,2-cyclohexanedicarboximide
- 164178-28-3/Urs-12-en-28-oic acid,3-[(3-O-b-D-glucopyranosyl-a-L-arabinopyranosyl)oxy]-, 6-O-b-D-glucopyranosyl-b-D-glucopyranosyl ester, (3b)-
- 65448-99-9/terkuronii
- 98216-05-8/Mammea B/BD
- 57-40-9/2-methyl-1-[(2-methylaziridin-1-yl)-phenyl-phosphoryl]aziridine
- 138-87-4/BETA-TERPINEOL
- 85945-10-4/Benzene,1-(1,2-diphenyl-1-butenyl)-4-(2- propenyloxy)-
- 512-17-4/7-[[(E)-3-Methyl-5-[(1S,2R,4R)-1,3,3-trimethyl-7-oxabicyclo[2.2.1]heptan-2-yl]-2-pentenyl]oxy]-2H-1-benzopyran-2-one
- 94441-95-9/N6-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-lysine, compound with cyclohexylamine (1:1)
